J B Chemicals &

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE572A01036
  • NSEID: JBCHEPHARM
  • BSEID: 506943
INR
2,196.00
0.05 (0.00%)
BSENSE

Jun 18

BSE+NSE Vol: 3.46 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Rubicon Research
Acutaas Chemical
Anthem Bioscienc
Ipca Labs
Gland Pharma
Sai Life
Emcure Pharma
Wockhardt
J B Chemicals &
Ajanta Pharma
Glaxosmi. Pharma
Why is J B Chemicals & Pharmaceuticals Ltd ?
1
High Management Efficiency with a high ROE of 18.05%
2
Company has a low Debt to Equity ratio (avg) at 0.02 times
3
Poor long term growth as Operating profit has grown by an annual rate 13.47% of over the last 5 years
4
Negative results in Mar 26
  • PAT(Q) At Rs 121.83 cr has Fallen at -35.4% (vs previous 4Q average)
  • ROCE(HY) Lowest at 23.67%
  • NET SALES(Q) Lowest at Rs 904.23 cr
5
Stock is technically in a Bullish range
  • The technical trend has improved from Mildly Bullish on 12-Jun-26 and has generated -2.75% returns since then
  • Multiple factors for the stock are Bullish like MACD, Bollinger Band, KST and DOW
6
With ROE of 17.5, it has a Very Expensive valuation with a 8.5 Price to Book Value
  • The stock is trading at a fair value compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 27.47%, its profits have risen by 10.7% ; the PEG ratio of the company is 6.6
7
High Institutional Holdings at 37.72%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to J B Chemicals & should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is J B Chemicals & for you?

Medium Risk, High Return

Absolute
Risk Adjusted
Volatility
J B Chemicals &
27.47%
1.14
24.08%
Sensex
-4.95%
-0.37
13.26%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
15.22%
EBIT Growth (5y)
13.47%
EBIT to Interest (avg)
72.96
Debt to EBITDA (avg)
0.26
Net Debt to Equity (avg)
-0.21
Sales to Capital Employed (avg)
1.08
Tax Ratio
25.50%
Dividend Payout Ratio
49.79%
Pledged Shares
0
Institutional Holding
37.72%
ROCE (avg)
27.10%
ROE (avg)
18.05%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
48
Industry P/E
34
Price to Book Value
8.48
EV to EBIT
37.17
EV to EBITDA
31.04
EV to Capital Employed
10.49
EV to Sales
8.29
PEG Ratio
6.62
Dividend Yield
1.31%
ROCE (Latest)
28.23%
ROE (Latest)
17.55%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Bullish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 145.87 cr

DEBTORS TURNOVER RATIO(HY)

Highest at 5.31 times

-16What is not working for the Company
PAT(Q)

At Rs 121.83 cr has Fallen at -35.4% (vs previous 4Q average

ROCE(HY)

Lowest at 23.67%

NET SALES(Q)

Lowest at Rs 904.23 cr

PBDIT(Q)

Lowest at Rs 201.13 cr.

OPERATING PROFIT TO NET SALES (Q)

Lowest at 22.24%

PBT LESS OI(Q)

Lowest at Rs 149.89 cr.

EPS(Q)

Lowest at Rs 6.31

Loading Valuation Snapshot...
Here's what is working for J B Chemicals &
Cash and Cash Equivalents - Half Yearly
Highest at Rs 145.87 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Debtors Turnover Ratio- Half Yearly
Highest at 5.31 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for J B Chemicals &
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 149.89 cr has Fallen at -36.8% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 237.00 Cr
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 121.83 cr has Fallen at -35.4% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 188.45 Cr
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Net Sales - Quarterly
At Rs 904.23 cr has Fallen at -13.7% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 1,048.26 Cr
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Net Sales - Quarterly
Lowest at Rs 904.23 cr
in the last five quarters
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Lowest at Rs 201.13 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Lowest at 22.24%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs 149.89 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Earnings per Share (EPS) - Quarterly
Lowest at Rs 6.31
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)